Citation Tools
PDFRegular and Young Investigator Award Abstracts
Combination Immunotherapies
895 Immunosuppressive signaling is activated in enzalutamide resistant prostate cancer
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 895 Immunosuppressive signaling is activated in enzalutamide resistant prostate cancer